Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)

SHE:300181 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	741.03	804.67	931.98	1,082	232.3	253.75
Trading Asset Securities	-	-	151	10.83	65.52	61.04
Cash & Short-Term Investments	741.03	804.67	1,083	1,093	297.82	314.79
Cash Growth	-26.85%	-25.70%	-0.91%	266.97%	-5.39%	126.93%
Accounts Receivable	1,143	783.33	532.42	510.07	337.33	308.18
Other Receivables	25.02	18.18	9.02	24.42	26.77	5.9
Receivables	1,169	801.52	541.44	534.5	364.1	314.08
Inventory	474.99	523.75	426.52	318.83	273.59	201.44
Prepaid Expenses	-	0	-	7.87	-	-
Other Current Assets	52.14	47.51	5.53	5.45	6.16	135.07
Total Current Assets	2,437	2,177	2,056	1,960	941.67	965.38
Property, Plant & Equipment	1,318	1,220	1,060	972.41	806.32	750.09
Long-Term Investments	465.65	254.64	179.7	392.36	650.67	463
Goodwill	130.32	130.32	130.32	130.32	130.32	130.32
Other Intangible Assets	74.29	75.08	71.27	63.04	64.89	70.2
Long-Term Deferred Tax Assets	31.26	30.4	25.5	25.14	15.51	14.41
Long-Term Deferred Charges	37.96	35.58	25.49	25.42	25.6	23.11
Other Long-Term Assets	74.81	68.91	78.07	74.76	113.55	53.37
Total Assets	4,569	3,992	3,627	3,643	2,749	2,470
Accounts Payable	538.03	482.41	433.85	468.88	296.77	200.63
Accrued Expenses	20.06	86.53	82.24	78.32	62.33	49.85
Short-Term Debt	461.19	377.31	193.06	138.16	178.2	302.85
Current Portion of Long-Term Debt	3.15	0.03	10.01	0.01	-	15.02
Current Portion of Leases	-	3.32	2.49	2.83	4.21	-
Current Income Taxes Payable	97.45	52.54	32.65	26.59	16.46	7.3
Current Unearned Revenue	5.79	14.45	2.23	14.14	3.06	1.56
Other Current Liabilities	86.05	39.46	38.28	26	23.55	21.83
Total Current Liabilities	1,212	1,056	794.83	754.94	584.58	599.04
Long-Term Debt	51.66	30.66	-	10	-	30.05
Long-Term Leases	17.33	18.27	16.69	22.13	24.27	-
Long-Term Unearned Revenue	25.72	26.5	19.9	19.76	22.37	25.48
Long-Term Deferred Tax Liabilities	81.54	41.03	21.68	76.24	134.1	95.86
Total Liabilities	1,388	1,173	853.09	883.07	765.31	750.43
Common Stock	701.39	701.39	701.39	701.39	608.62	608.62
Additional Paid-In Capital	1,110	1,135	1,135	1,135	340.48	340.48
Retained Earnings	1,223	1,041	849.32	676.8	525.52	396.19
Treasury Stock	-122.15	-203.97	-	-	-	-
Comprehensive Income & Other	207.63	94.63	42.66	190.19	369.44	257.52
Total Common Equity	3,119	2,769	2,729	2,704	1,844	1,603
Minority Interest	61.95	50.56	45.2	56.18	139.15	116.63
Shareholders' Equity	3,181	2,819	2,774	2,760	1,983	1,719
Total Liabilities & Equity	4,569	3,992	3,627	3,643	2,749	2,470
Total Debt	533.33	429.59	222.25	173.13	206.67	347.92
Net Cash (Debt)	207.7	375.08	860.73	919.77	91.15	-33.13
Net Cash Growth	-74.39%	-56.42%	-6.42%	909.09%	-	-
Net Cash Per Share	0.30	0.54	1.24	1.52	0.15	-0.05
Filing Date Shares Outstanding	692.47	692.47	701.39	701.39	608.62	608.62
Total Common Shares Outstanding	692.47	686.49	701.39	701.39	608.62	608.62
Working Capital	1,225	1,121	1,262	1,205	357.1	366.33
Book Value Per Share	4.50	4.03	3.89	3.85	3.03	2.63
Tangible Book Value	2,915	2,563	2,527	2,510	1,649	1,402
Tangible Book Value Per Share	4.21	3.73	3.60	3.58	2.71	2.30
Buildings	-	1,014	962.71	832.63	678.11	660.12
Machinery	-	529.12	467.55	432.59	412.82	395.27
Construction In Progress	-	161.43	61.14	78.06	40.29	0.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.